Johnson & Johnson CEDEAR (JNJD)
BCBA
Closed
Aug 21, 2026
Day's Range
18.6052 wk Range
11.45Overview - JNJD - Johnson & Johnson CEDEAR
Key Statistics
Valuation
Enterprise Value
701.61B
P/E (Trailing)
‪0.30‬
Price / Book
‪7.91‬
EV / EBITDA
‪20.12‬
Profitability
Profit Margin
‪21.48%‬
Operating Margin
‪29.19%‬
Return on Assets
‪8.59%‬
Return on Equity
‪25.74%‬
Ownership
Float
35.91B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.05%‬
Price stats
Beta
‪0.23‬
50-Day Avg
‪17.58‬
200-Day Avg
‪15.89‬
Dividends
Frequency
Quarterly
Peers - JNJD - Johnson & Johnson CEDEAR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- JNJDBCBAJohnson & Johnson CEDEAR+36.43%52-week change0.30P/E (Trailing)‪21.48%‬Profit Margin
- SANBCBABanco Santander, S.A. CEDEAR+43.62%52-week change60.24P/E (Trailing)‪33.46%‬Profit Margin
- BMYBCBABristol-Myers Squibb Co.+40.06%52-week change5.24P/E (Trailing)‪18.87%‬Profit Margin
- MRKBCBAMerck & Co., Inc. CEDEAR+52.12%52-week change2.59P/E (Trailing)‪4.76%‬Profit Margin
- LLYBCBAEli Lilly and Company CEDEAR+52.71%52-week change0.20P/E (Trailing)‪33.52%‬Profit Margin
- BIIBBCBABiogen Inc. CEDEAR+46.31%52-week change3.15P/E (Trailing)‪8.32%‬Profit Margin
- AMGNBCBAAmgen Inc.+43.97%52-week change0.19P/E (Trailing)‪22.95%‬Profit Margin
Profile Summary - JNJD - Johnson & Johnson CEDEAR
About
Johnson & Johnson CEDEAR is an Argentine depositary receipt that represents an economic interest in Johnson & Johnson’s ordinary shares, allowing local investors to access the company’s global healthcare exposure in pesos through Argentina’s capital market. Each receipt represents a fractional interest designed to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
